Because there are no tumor studies in the presence of BPC-157 or long-term human studies, supplemental use should be cautioned
J Neuroimmunol 2012;251:80-6
It is also explored for its ability to enhance wound healing and support faster tissue recovery
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
At Perfect B, every patient who qualifies for a CJC-1295 with Ipamorelin protocol starts with a clinical intake, body composition assessment, and baseline IGF-1 measurement